Katja Rudell

Katja provides strategic and scientific guidance on robust design, implementation, and dissemination of patient-centric projects to support the product life cycle. She has extensive experience in clinical research, and works with pharmaceutical and academic teams across various therapeutic areas. Katja’s background includes developing and validating patient-reported outcome measures in asthma, COPD, diabetic neuropathy, neurology, and device-satisfaction treatment tools. She holds a PhD in psychology as applied to medicine from Barts and the London School of Medicine and Dentistry at Queen Mary University of London.